Related Experiment Video

Updated: Aug 12, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Comparison of target concentration intervention strategy with conventional dosing of digoxin

S D Rajendran1, Y Madhusudan Rao, S Thanikachalam

  • 1Department of Pharmacy Practice, JSS College of Pharmacy, Ootacamund 643 001. sdrajendran@rediffmail.com

Indian Heart Journal
|October 4, 2005
PubMed

Insights

Continuous digoxin dosing improved quality of life for congestive heart failure patients. Maintaining target serum digoxin concentrations with 7/7 therapy showed significant benefits over 5/7 therapy.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Digoxin is a common medication for patients diagnosed with congestive heart failure.
  • Optimizing digoxin dosage is crucial for managing heart failure symptoms and improving patient outcomes.

Purpose of the Study:

  • To compare the quality of life in congestive heart failure patients using two different digoxin dosing regimens: 5/7 therapy versus 7/7 therapy.
  • To determine if continuous digoxin dosing, maintaining target serum concentrations, impacts patient quality of life over a one-year period.

Main Methods:

  • A one-year follow-up study comparing two digoxin dosing strategies (5/7 and 7/7 therapy).
  • Serum digoxin concentrations were monitored to ensure target levels were maintained in both groups.
  • Quality of life assessments were conducted for all participating patients.

Main Results:

  • Patients in the intervention group (7/7 therapy) demonstrated a significant improvement in their quality of life.
  • The continuous dosing regimen (7/7 therapy) was associated with enhanced patient well-being compared to the intermittent regimen (5/7 therapy).

Conclusions:

  • Continuous digoxin dosing, guided by target serum concentrations, is essential for improving the quality of life in congestive heart failure patients.
  • The 7/7 digoxin therapy regimen offers superior benefits for patient quality of life compared to the 5/7 regimen.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Related Concept Videos

Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...